Syneos Health is pleased to work together with Octane in advancing progress in innovation in the life sciences, both in drugs and biologics and also specifically in the realm of medical devices and diagnostics (MD&D). Syneos Health is the only fully integrated biopharmaceutical solutions organization. The company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Syneos Health brings together approximately 28,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Syneos Health has a dedicated division of medical device and diagnostic experts who enjoy many decades of experience advising and supporting companies of all sizes from product concept to commercialization.
Syneos Health executives such as Brian Hoffman (VP Business Development), Dr. Timothy Pratt, PhD (Executive Director – Clinical Development), and David Byram (Managing Director, Value Access & Reimbursement) regularly meet with Octane leadership in an advisory capacity for the Octane MedTech Innovation Forum, serving as Subject Matter Experts for panels, and connecting with companies with specific needs to help them to the next stage of the product lifecycle.
As Brian Hoffman likes to say, “It’s not about sales, it’s about getting alongside early-stage companies to help them realize their vision in the most efficient and productive manner possible.” This sentiment is mirrored by Rachel Hoffman,* Vice President & Global Head Syneos Health MD&D division, “It’s an honor to be at the cutting edge of innovation with Octane and the companies they serve – to see the level of thought and inventiveness is exciting when you realize how patients’ lives can be positively impacted. When you consider the expert consulting, Reimbursement and Regulatory Strategy formulation, Clinical Trial design and operationalization we can bring to bear, with the power of a global organization focused down into a team of dedicated MD&D experts to help these companies be successful, quite frankly, it is one of the most satisfying parts of our roles. We’re happy to engage with companies of all sizes and therapy areas – most of our work in MD&D is with small to mid-sized organizations.”
Syneos Health MD&D operates as a smaller specialized standalone unit within the framework of the larger Syneos Health organization. The MD&D team benefits from the significant resources of Syneos Health globally, including staff medical experts in a comprehensive array of therapeutic areas, world-class biostatisticians, field clinical trainers and engineers, and strategy groups for reimbursement, regulatory, clinical, biocompatibility and lab services. Syneos Health site feasibility experts aim to target exact investigators and populations with precise projected trial enrollment rates. In the past five years, the MD&D group has mapped out supporting strategies and clinical trials, engaging in over 270 projects across 6,150+ sites and touching nearly 152,000 trial subjects.
* Unrelated except for a common passion in helping companies bring life-changing therapies to market.
Let Us Know What You Thought about this Post.
Put your Comment Below.